Richard Manning, a highly respected former chair of the Development Assistance Committee (DAC) says in the FT that the OECD is "encouraging OECD finance ministries to get away with murder as they seek to massage reported aid upwards at minimum cost."
Over 100 countries have adopted national renewable power targets, with particular focus on wind and solar power (WSP). WSP offers many socioeconomic and environmental benefits but it has two major drawbacks: 1) it's comparatively costly and 2) it's not always available when we need it (i.e. intermittency).
Latin America’s distribution of income and wealth has long been the most unequal in the world—but poverty and inequality have been falling consistently since 2000 in most countries of the region. What has changed in Latin America? Are the region’s governments more committed to equality than in the past? Have their tax and spending policies improved? Which governments are most committed? Which least? What policies and programs have been most effective in redistributing income? Are they sustainable? What is holding Latin America back from faster gains?
Last week CGD released a new working paper that I’ve been working on—together with my co-authors Tessa Bold, Mwangi Kimenyi, Germano Mwabu, and Alice Ng’ang’a—since I was a grad student in 2007. “Scaling Up What Works: Experimental Evidence on External Validity i
Last week saw a series of news stories break around the world, in what may have been the largest ever cross-border journalistic collaboration. The stories, coordinated by the International Consortium of Investigative Journalists (ICIJ), are based on a major leak of files from company formation agents operating primarily in the British Virgin Islands and the Cook Islands.
This post was originally published in The Broker.
This post originally appeared on the Peterson Institute for International Economics blog.
On April 1, the Indian Supreme Court rejected the attempt by Novartis, the Swiss pharmaceutical company, to patent a new version of the leukemia drug Glivec. The latest verdict follows previous rulings that granted compulsory licenses to an Indian generic drug manufacturer for a kidney cancer drug (Nexavar) patented by Bayer. Five important questions are raised by these rulings.
I and all my colleagues at the Center for Global Development (CGD) are thrilled with the announcement today that CGD senior fellow, Michael Clemens, has won this year’s Royal Economic Society prize - a prize awarded annually to the author(s) of the best non-solicited paper published in The Economic Journal
The World Bank just wrapped up a public consultation on the Doing Business report as part of a closely-watched independent review of the report led by Trevor Manuel.
I’ll tell you what I think about Doing Business, but first I need to let you in on a little secret about policymakers. Here it is: you need to keep it simple for them.
Owen Barder is sceptical about a proposed new public-private partnership to tackle hunger.